You have 9 free searches left this month | for more free features.

selinexor

Showing 1 - 25 of 101

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Myelofibrosis, Moderate Thrombocytopenia Trial (Selinexor)

Not yet recruiting
  • Myelofibrosis
  • Moderate Thrombocytopenia
  • Selinexor
  • (no location specified)
Jul 31, 2023

Acute Myeloid Leukemia (Relapsed/Refractory) Trial in Suzhou (Selinexor, Chidamide)

Recruiting
  • Acute Myeloid Leukemia (Relapsed/Refractory)
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Jul 16, 2023

Ovarian Cancer Trial in Maywood (Decitabine, Carboplatin, Paclitaxel)

Not yet recruiting
  • Ovarian Cancer
  • Maywood, Illinois
    Loyola University Medical Center
Aug 1, 2023

Multiple Myeloma in Relapse Trial in Aurora (Selinexor, Pomalidomide, Daratumumab)

Recruiting
  • Multiple Myeloma in Relapse
  • Selinexor
  • +4 more
  • Aurora, Colorado
    University of Colorado Hospital
Jan 31, 2023

Selinexor in Relapsed or Refractory Multiple Myeloma - SEATTLE-

Recruiting
  • Multiple Myeloma
  • Selinexor
  • Wien, Austria
  • +1 more
Jul 13, 2023

Rhabdoid Tumor, Atypical Teratoid/Rhabdoid Tumor, Atypical Teratoid/Rhabdoid Tumor of CNS Trial in Memphis (Idasanutlin,

Not yet recruiting
  • Rhabdoid Tumor
  • +3 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Jul 11, 2023

Multiple Myeloma, Myeloma-Associated Amyloidosis Trial in Saint Louis (Selinexor, Lenalidomide, Dexamethasone)

Not yet recruiting
  • Multiple Myeloma
  • Myeloma-Associated Amyloidosis
  • Selinexor
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Apr 6, 2023

PTCL Patients Who Achieved Complete Response From Frontline Treatment Trial (Selinexor)

Not yet recruiting
  • PTCL Patients Who Achieved Complete Response From Frontline Treatment
  • Selinexor
  • (no location specified)
Apr 18, 2023

Selinexor-based Regimens for Treatment of Non-Hodgkin Lymphoma

Recruiting
  • Lymphoma
  • +2 more
  • Selinexor
  • Shanghai, Shanghai, China
  • +2 more
May 9, 2023

Relapsed/Refractory AML Trial in Suzhou (Selinexor, Homoharringtonine, Cytarabine)

Not yet recruiting
  • Relapsed/Refractory AML
  • Selinexor
  • +6 more
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Mar 28, 2023

Multiple Myeloma Trial in West Hollywood, Cary (Selinexor, Placebo (for selinexor), carfilzomib)

Withdrawn
  • Multiple Myeloma
  • Selinexor
  • +3 more
  • West Hollywood, California
  • +1 more
Jan 24, 2023

EBV-Positive DLBCL, Nos Trial in Guangzhou, Shanghai (Selinexor, R-CHOP Protocol)

Recruiting
  • EBV-Positive Diffuse Large B-Cell Lymphoma, Nos
  • Selinexor
  • R-CHOP Protocol
  • Guangzhou, Guangdong, China
  • +1 more
Nov 10, 2022

Coronavirus Infection Trial (Selinexor)

Withdrawn
  • Coronavirus Infection
  • Selinexor
  • (no location specified)
Jan 19, 2023

Smoldering Multiple Myeloma Trial (Selinexor)

Not yet recruiting
  • Smoldering Multiple Myeloma
  • Selinexor
  • (no location specified)
Oct 27, 2022

Relapsed or Refractory Acute Myeloid Leukemia Trial in Taiyuan (Selinexor, Homoharringtonine, Daunorubicin)

Recruiting
  • Relapsed or Refractory Acute Myeloid Leukemia
  • Selinexor
  • +5 more
  • Taiyuan, Shanxi, China
    Tao Wang
Feb 9, 2023

Myeloma Multiple, Myeloma, Refractory Multiple Myeloma Trial in Brooklyn, New York (Selinexor, Clarithromycin, Pomalidomide)

Terminated
  • Myeloma Multiple
  • +2 more
  • Selinexor
  • +3 more
  • Brooklyn, New York
  • +1 more
Jan 24, 2023

DLBCL, Not Otherwise Specified Trial in Chongqing (selinexor)

Recruiting
  • Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
  • selinexor
  • Chongqing, Chongqing, China
    Chongqing University Cancer Hospital
Mar 27, 2023

Metastatic Colorectal Cancer Trial in Los Angeles, Newark, Plantation (Selinexor, Pembrolizumab, Trifluridine)

Terminated
  • Metastatic Colorectal Cancer
  • Selinexor
  • +3 more
  • Los Angeles, California
  • +2 more
Jan 24, 2023

Myelofibrosis Trial in United States (Selinexor, Ruxolitinib)

Recruiting
  • Myelofibrosis
  • Duarte, California
  • +4 more
Jan 30, 2023

Glioblastoma, Glioma Trial in Denmark, Netherlands, United States (Selinexor)

Terminated
  • Glioblastoma
  • Glioma
  • Selinexor
  • Boston, Massachusetts
  • +5 more
Jan 24, 2023

CNS Lymphoma Trial in China (Selinexor, Rituximab, Methotrexate)

Not yet recruiting
  • Central Nervous System Lymphoma
  • Selinexor
  • +2 more
  • Hefei, Anhui, China
  • +4 more
Jan 26, 2023

Multiple Myeloma Trial in Tampa (Selinexor, Melphalan, Dexamethasone)

Completed
  • Multiple Myeloma
  • Selinexor
  • +4 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Nov 2, 2022

Leukemia, Acute Myeloid Leukemia, AML Trial in Tampa (Selinexor, Daunorubicin, Cytarabine)

Completed
  • Leukemia
  • +2 more
  • Selinexor
  • +2 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Sep 30, 2022

Endometrial Cancer Trial in Israel, United States (Selinexor, Matching Placebo for selinexor)

Recruiting
  • Endometrial Cancer
  • Selinexor
  • Matching Placebo for selinexor
  • Miami Beach, Florida
  • +6 more
Jan 31, 2023

Recurrent Histiocytic and Dendritic Cell Tumor, Recurrent Non-Hodgkin Lymphoma, Refractory Histiocytic and Dendritic Cell Tumor

Recruiting
  • Recurrent Histiocytic and Dendritic Cell Neoplasm
  • +3 more
  • Choline Salicylate
  • Selinexor
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Dec 5, 2022